MX2007010407A - Formulacion con accion anti-tumor. - Google Patents

Formulacion con accion anti-tumor.

Info

Publication number
MX2007010407A
MX2007010407A MX2007010407A MX2007010407A MX2007010407A MX 2007010407 A MX2007010407 A MX 2007010407A MX 2007010407 A MX2007010407 A MX 2007010407A MX 2007010407 A MX2007010407 A MX 2007010407A MX 2007010407 A MX2007010407 A MX 2007010407A
Authority
MX
Mexico
Prior art keywords
oligodeoxyribonucleotides
dalton
treating tumors
tumors
produced
Prior art date
Application number
MX2007010407A
Other languages
English (en)
Spanish (es)
Inventor
Laura Iris Ferro
Massimo Iacobelli
Gunther Eissner
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT000336A external-priority patent/ITMI20050336A1/it
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of MX2007010407A publication Critical patent/MX2007010407A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2007010407A 2005-03-03 2006-02-27 Formulacion con accion anti-tumor. MX2007010407A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000336A ITMI20050336A1 (it) 2005-03-03 2005-03-03 Formulazione ad attivita' anti-tumorale
US73140405P 2005-10-28 2005-10-28
PCT/EP2006/060306 WO2006094917A2 (en) 2005-03-03 2006-02-27 Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors

Publications (1)

Publication Number Publication Date
MX2007010407A true MX2007010407A (es) 2007-10-17

Family

ID=36572331

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2007010407A MX2007010407A (es) 2005-03-03 2006-02-27 Formulacion con accion anti-tumor.
MX2007010754A MX2007010754A (es) 2005-03-03 2006-02-27 Defibrotide y/u oligodeoxiribonucleotidos para tratar tumores dependientes de angiogenesis.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2007010754A MX2007010754A (es) 2005-03-03 2006-02-27 Defibrotide y/u oligodeoxiribonucleotidos para tratar tumores dependientes de angiogenesis.

Country Status (9)

Country Link
US (2) US20080194507A1 (enExample)
EP (2) EP1855697A2 (enExample)
JP (2) JP2008531647A (enExample)
KR (3) KR20070120953A (enExample)
AU (2) AU2006222045B2 (enExample)
CA (2) CA2598613A1 (enExample)
IL (3) IL185182A0 (enExample)
MX (2) MX2007010407A (enExample)
WO (2) WO2006094916A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031714A1 (it) 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
US8187897B2 (en) 2008-08-19 2012-05-29 International Business Machines Corporation Fabricating product chips and die with a feature pattern that contains information relating to the product chip
EP2637672B1 (en) 2010-11-12 2018-08-22 Gentium S.r.l. Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
KR102038357B1 (ko) 2012-06-22 2019-10-31 젠티엄 에스알엘 디파이브로타이드의 생물학적 활성 측정을 위한 유우글로불린에 기초한 방법
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
EP3661484A1 (en) 2017-08-03 2020-06-10 Jazz Pharmaceuticals Ireland Limited Formulations comprising a nucleic acid in a high concentration
WO2019200251A1 (en) 2018-04-12 2019-10-17 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
US20230190783A1 (en) 2020-02-28 2023-06-22 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en) * 1985-05-28 1987-09-15 Ajax Magnethermic Corporation Apparatus for overheating edges of skelp for the production of compression welded pipe
IT1190313B (it) * 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
US5223609A (en) * 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
IT1252174B (it) * 1991-12-09 1995-06-05 Crinos Industria Farmaco Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento
US5578716A (en) * 1993-12-01 1996-11-26 Mcgill University DNA methyltransferase antisense oligonucleotides
CA2259041A1 (en) * 1997-04-28 1998-11-05 Arsinur Burcoglu Method of treating hiv infection and related secondary infections thereof
AU8125098A (en) * 1997-05-30 1998-12-30 Mcgill University Dna methyltransferase genomic sequences and antisense oligonucleotides
DE19740384A1 (de) * 1997-09-08 1999-03-11 Max Delbrueck Centrum Antisense Oligodesoxynukleotide (ODN) gegen Proteinkinase C (PKC)-Isoformen, ihre Verwendung und pharmazeutische Zubereitungen dieser ODN
AU2002353783A1 (en) * 2001-09-24 2003-04-07 The Government Of The United States Of America As Represented By The Secretary Of The Department Of SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.

Also Published As

Publication number Publication date
AU2006222044A1 (en) 2006-09-14
EP1853277A1 (en) 2007-11-14
AU2006222045A1 (en) 2006-09-14
MX2007010754A (es) 2007-11-07
KR20070121001A (ko) 2007-12-26
WO2006094917A2 (en) 2006-09-14
WO2006094917A3 (en) 2006-12-14
AU2006222045B2 (en) 2011-10-20
CA2598072C (en) 2016-05-03
US20080194507A1 (en) 2008-08-14
CA2598072A1 (en) 2006-09-14
JP2008531647A (ja) 2008-08-14
KR20070120953A (ko) 2007-12-26
US20080194506A1 (en) 2008-08-14
CA2598613A1 (en) 2006-09-14
IL185181A0 (en) 2008-01-20
KR20070120954A (ko) 2007-12-26
WO2006094916A1 (en) 2006-09-14
WO2006094917A8 (en) 2008-01-31
IL185258A (en) 2010-12-30
JP5714203B2 (ja) 2015-05-07
IL185182A0 (en) 2008-01-20
EP1855697A2 (en) 2007-11-21
IL185258A0 (en) 2008-02-09
JP2008531646A (ja) 2008-08-14

Similar Documents

Publication Publication Date Title
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
WO2006094917A3 (en) Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors
MX349144B (es) Supresion de tumores utilizando perfundido placentario humano y celulas destructoras naturales intermediarias derivadas de la placenta humana.
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
WO2008137867A3 (en) Compositions comprising mir34 therapeutic agents for treating cancer
EA201000322A1 (ru) Композиции и способы для обработки семян
IL185281A0 (en) Compositions and methods for topical application and transdermal delivery of an oligopeptide
UA111464C2 (uk) Композиція, що містить моногліцериди органічних кислот c1-c7 та гліцерин, та її застосування як протибактеріального та протипліснявого засобу
EA200901074A1 (ru) Лечение метастатической стадии рака предстательной железы дегареликсом
MX2012003851A (es) Tratamiento de cánceres resistentes antagonistas notch1, mediante el uso de antagonistas notch3.
NZ597075A (en) 1, 2, 4-thiazolidin-3-one derivatives as AMP-activated protein kinase (AMPK) agonists for treating cancer
WO2007038868A3 (en) Novel enediyne compound and uses thereof
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
WO2009105457A3 (en) Slit2 cancer markers
WO2008134752A3 (en) Methods and compositions for the treatment of cancer
WO2014028939A3 (en) Targeting phosphofructokinase and its glycosylation form for cancer
WO2008066775A3 (en) Compositions and methods to reduce fat and retract skin
WO2008033887A3 (en) Methods for treating cancer
WO2013066485A3 (en) Compositions and methods for treatment of metastatic cancer
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN
TW200738143A (en) Use of arylanilides for seed treatment
WO2008148474A3 (de) Lösungen für die perfusion und konservierung von organen und geweben
MD3437G2 (ro) Procedeu de tratare a seminţelor de ardei gras înainte de semănat
ZA200707417B (en) Oligodeoxyribonucleotides of 4000-10000 Dalton for treating tumors
WO2011076095A8 (en) Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells

Legal Events

Date Code Title Description
FA Abandonment or withdrawal